Evaluation of the Uterine Cavity After Operative Hysteroscopy

July 13, 2026 updated by: Mai Allam Mohamed, Sohag University
This study will focus on evaluation of the uterine cavity after operative hysteroscopy using three dimensional transvaginal ultrasonography and office hysteroscopy to detect and residual or recurrent abnormalities or intrauterine adhesions to optimize the results of operative hysteroscopy in different uterine pathologies such as uterine polyps, fibroids, adhesions in addition to mullerian anomalies especially uterine septum .

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Sohag, Egypt, 82511
        • Sohag University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

It will be held in the department of Obstetrics and Gynecology during the period from February 2025 to February 2026. The study will include all recruited patients who will be selected for operative hysteroscopy during that period.

Description

Inclusion Criteria:

  1. Patients in reproductive age group
  2. Patients already selected for operative hysteroscopy
  3. Patients accepted to share in the study
  4. Patients accepted to come for follow up ( within 3 months after the initial operative procedure, at least after 4 weeks

Exclusion Criteria:

  1. Patients outside the age of reproduction
  2. Patients with negative findings at operative hysteroscopy
  3. Patients refused to share in the study
  4. Patients not available for follow up
  5. Infection
  6. pregnancy or design of pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of bias in 3 dimensional ultrasonography compared to office hysteroscopy
Time Frame: one year
Comparing three dimensional ultrasonography and office hysteroscopy for uterine cavity evaluation after operative hysteroscopy as regards accuracy, pain score, and cost-effectiveness of each method.
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Concentration of the risks and benefits between 3 dimensional ultrasonography and office hysteroscopy
Time Frame: 1 year
To compare three dimensional ultrasonography with office hysteroscopy in evaluation of the uterine cavity after operative hysteroscopy and if the non invasive procedure can replace the invasive one or not
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with infertility , abnormal uterine bleeding and dysparunia
Time Frame: 1 year
all cases in this study already underwent operative hysteroscopy for a specific complaint
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2025

Primary Completion (Actual)

March 31, 2026

Study Completion (Actual)

June 8, 2026

Study Registration Dates

First Submitted

April 6, 2025

First Submitted That Met QC Criteria

April 6, 2025

First Posted (Actual)

April 11, 2025

Study Record Updates

Last Update Posted (Actual)

July 14, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--25-3-05MS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe